ADAMTS13 and Decreased liver function: A previous study reported a decrease of ADAMTS13-Act in cirrhotic patients (n = 90) with CTP stages B and C (but not CTP-A) [34] and similar results were reported among ACLD patients with severe impairment of liver dysfunction [35, 36].